Glow is a physician-prescribed compounded blend of three peptides: GHK-Cu, a copper peptide studied for skin structure and tissue quality, alongside BPC-157 and TB-500, two peptides frequently prescribed together for tissue repair. Rather than treating skin from the outside with a cream, Glow is formulated as an injectable so all three actives reach skin tissue systemically. GHK-Cu drives tone and radiance at the surface level, while BPC-157 and TB-500 support the deeper tissue repair underneath.

GHK-Cu stimulates collagen and glycosaminoglycan synthesis and supports the fibroblasts that rebuild skin's structural matrix, along with antioxidant and anti-inflammatory effects. BPC-157 concentrates its repair effects at sites of tissue damage, while TB-500 circulates systemically to support cell migration and remodeling. Administered together by injection, the blend supports skin tone, texture, and firmness from within.

People looking to improve skin tone evenness and radiance, those interested in supporting collagen and skin structure as they age, people who prefer a systemic protocol over topical skincare, and patients already in a Live Vital skin-health protocol seeking a complementary option.

Many patients report early changes in skin quality within the first few weeks, with tone and texture improvements typically building over a full three-month course as collagen remodeling progresses.

Commonly reported side effects include injection site redness or irritation, mild transient skin irritation, and, less often, nausea, headache, temporary fatigue, or rare temporary skin discoloration. Glow is not appropriate with active cancer or a history of malignancy, known copper sensitivity or Wilson disease, during pregnancy or breastfeeding, with an active injection-site infection, with active liver or kidney disease, alongside anticoagulant medications without supervision, with a heavy-metal allergy, or with zinc or vitamin C deficiency. GHK-Cu, BPC-157, and TB-500 are not FDA-approved; Glow is prescribed off-label under physician supervision after intake and informed consent.